SVB Leerink Begins Coverage on Neurogene (NASDAQ:NGNE)
SVB Leerink initiated coverage on shares of Neurogene (NASDAQ:NGNE – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued an outperform rating and a $46.00 target price on the stock. Several other equities analysts have also commented on the stock. Stifel Nicolaus initiated coverage on shares of Neurogene in […]
More Stories
People Are Losing Billions Through Social Media Scams, FTC Says
By Jackson Richman Americans are losing billions of dollars to scams that begin on social media, according to new data...
US Accuses China of ‘Industrial-Scale’ AI Theft Ahead of Trump’s Visit
By Michael Zhuang The White House has issued a sharply worded memo accusing China-linked entities of systematically stealing U.S. artificial...
CDC Investigating Multi-State Salmonella Outbreak Linked to Backyard Poultry
By Jack Phillips The Centers for Disease Control and Prevention has said it is investigating an outbreak of salmonella bacterial...
US Allows Venezuela to Fund Maduro’s Defense After Court Challenge
By Tom Gantert The United States will ease sanctions on Venezuela to allow its regime to pay legal fees for...
Monsanto Weedkiller Case Could Upend Billions in Compensation
By Troy Myers and Jacob Burg Like countless homeowners, John Durnell of Missouri used a popular herbicide to keep his...
Planned Obsolescence: The Silent Sabotage of the Devices We Depend On
By Stephen Zogopoulos, USNN World News The Illusion of Progress Walk into any electronics store today and you’ll see the...